First Episode Psychosis: Focus On US Hispanic Population

Name: First Episode Psychosis: Focus On US Hispanic Population
Start: 2021-12-08T12:00:00-05:00
End: 2021-12-08T13:00:00-05:00

Webinar December 8, 2021 12:00 pm to 1:00 pm EST

First Episode Psychosis: Focus On US Hispanic Population

This presentation will review concepts of First Episode Psychosis (FEP) and Coordinated Specialty Care (CSC) while focusing on the cultural considerations for treatment, outcomes, and research for the US Hispanic FEP patient population.

Mauricio Tohen, MD, DrPH, MBA, is University Distinguished Professor and Chairman of the Department of Psychiatry & Behavioural Sciences at the University of New Mexico HSC in Albuquerque NM, USA. In 2014 Dr Tohen was recognized in Thomson Reuter’s “The World’s Most Influential Scientific Minds, 2014”. He is one of 100 scientists worldwide recognized in the Psychiatry/Psychology category. Dr Tohen has published over 350 publications, and has over 20,000 scientific citations. In 2016 the International Society for Bipolar Disorders awarded him the Mogens Schou award for Education and Teaching. In 2017, Dr Tohen was recognized by Expertscape as having the top 0.12% expertise in bipolar disorder worldwide based on citations of published articles between 2007-2017.

Stephen Murray, MBA, PharmD, is a Senior Neuroscience Medical Science Liaison within Field Medical Affairs at Otsuka America Pharmaceutical.

Featuring

Mauricio Tohen, MD, DrPH, MBA

Professor & Chairman, Department Of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center
Stephen Murray, PharmD, MBA (OPDC)

Senior Medical Science Liaison

Dr. Mauricio Tohen is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. Stephen Murray is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.